1LyMwl4

CONSENSO DE VALVULOPATÍAS 37
90. Nojek C, Scattini G. ¿Reparación valvular o reemplazo en la
insuficiencia mitral? Cap Cardiol 1997;5:368.
91. Gammie JS, Sheng S, Griffith BP, Peterson ED, Rankin JS,
O’Brien S, et al. Trends in mitral valve surgery in the United States:
results from the Society of Thoracic Surgeons Adult Cardiac Surgery
Database. Ann Thorac Surg 2009;87:1431-9.
92. The European Association for Cardio-Thoracic Surgery. Fourth
EACTS adult cardiac surgical database report 2010. Henley-on-
Thames, UK: Dendrite Clinical Systems Ltd, 2010.
93. Bridgewater B, Keogh B, Kinsman R, Walton P. The Society for
Cardiothoracic Surgery in Great Britain & Ireland, 6th national adult
cardiac surgical database report; demonstrating quality, 2008. Henleyon-Thames,
UK: Dendrite Clinical Systems Ltd, 2009.
94. Gummert JF, Funkat A, Beckmann A, Schiller W, Hekmat K,
Ernst M, et al. Cardiac surgery in Germany during 2009. A report
on behalf of the German Society for Thoracic and Cardiovascular
Surgery. Thorac Cardiovasc Surg 2010;58:379-86.
95. Gammie JS, O’Brien SM, Griffith BP, Ferguson TB, Peterson ED.
Influence of hospital procedural volume on care process and mortality
for patients undergoing elective surgery for mitral regurgitation.
Circulation 2007;115:881-7.
96. The Society of Thoracic Surgeons. Adult cardiac surgery database,
executive summary, 10 years STS report. Datos publicados en el sitio
STS. http://www.sts.org/sites/default/files/documents/20112ndHarve
stExecutiveSummary.pdf
97. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, et
al; EVEREST II Investigators. Percutaneous repair or surgery for
mitral regurgitation. N Engl J Med 2011;364:1395-406.
98. Franzen O, Baldus S, Rudolph V, Meyer S, Knap M, Koschyk D,
et al. Acute outcomes of MitraClip therapy for mitral regurgitation
in high-surgical-risk patients: emphasis on adverse valve morphology
and severe left ventricular dysfunction. Eur Heart J 2010;31:1373-81.
99. Mauri L, Garg P, Massaro JM, Foster E, Glower D, Mehoudar P,
et al. The EVEREST II Trial: design and rationale for a randomized
study of the evalve mitraclip system compared with mitral valve
surgery for mitral regurgitation. Am Heart J 2010;160:23-9.
100. Otsuji Y, Handschumacher MD, Schwammenthal E, Jiang L,
Song JK, Guerrero JL, et al. Insights from three-dimensional echocardiography
into the mechanism of functional mitral regurgitation:
direct in vivo demonstration of altered leaflet tethering geometry.
Circulation 1997;96:1999-2008.
101. Watanabe N, Ogasawara Y, Yamaura Y, Kawamoto T, Akasaka
T, Yoshida K. Geometric deformity of the mitral annulus in patients
with ischemic mitral regurgitation: a real-time three-dimensional
echocardiographic study. J Heart Valve Dis 2005;14:447-52.
102. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik
AJ. Determinants of the degree of functional mitral regurgitation
in patients with systolic left ventricular dysfunction: a quantitative
clinical study. Circulation 2000;102:1400-6.
103. Levine RA, Schwammenthal E. Ischemic mitral regurgitation
on the threshold of a solution. From paradoxes to unifying concepts.
Circulation 2005;112:745-58.
104. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ.
Ischemic mitral regurgitation: long-term outcome and prognostic
implications with quantitative Doppler assessment. Circulation
2001;103:1759-64.
105. Trichon BH, Felker GM, Shaw LK, Cabell CH, O’Connor CM.
Relation of frequency and severity of mitral regurgitation to survival
among patients with left ventricular systolic dysfunction and heart
failure. Am J Cardiol 2003;91;538-43.
106. Bursi F, Barbieri A, Grigioni F, Reggianini L, Zanasi V, Leuzzi
C, et al. Prognostic implications of functional mitral regurgitation
according to the severity of the underlying chronic heart failure: a
long-term outcome study. Eur J Heart Fail 2010;12:382-8.
107. Lancellotti P, Gerard P, Pierard L. Long term outcome of patients
with heart failure and dynamic functional mitral regurgitation. Eur
Heart J 2005;26:1528-32.
108. van Bommel RJ, Marsan NA, Delgado V, Borleffs CJW, van Rijnsoever
EPM, Schalij MJ, et al. Cardiac resynchronization therapy as a
therapeutic option in patients with moderate-severe functional mitral
regurgitation and high operative risk. Circulation 2011;124:912-9.
109. McGee EC Jr, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen
G, Najam F, et al. Recurrent mitral regurgitation after annuloplasty
for functional ischemic mitral regurgitation. J Thorac Cardiovasc
Surg 2004;128:916-24.
110. Mihaljevic T, Lam BK, Rajeswaran J, Takagaki M, Lauer MS,
Gillinov AM, et al. Impact of mitral valve annuloplasty combined
with revascularization in patients with functional ischemic mitral
regurgitation. J Am Coll Cardiol 2007;49:2191-201.
111. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling
TM. Impact of mitral valve annuloplasty on mortality risk in patients
with mitral regurgitation and left ventricular systolic dysfunction. J
Am Coll Cardiol 2005;45:381-7.
112. Fattouch K, Guccione F, Sampognaro S, Panzarella G, Corrado
E, Navarra E, et al. Efficacy of adding mitral valve restrictive annuloplasty
to coronary artery bypass grafting in patients with moderate
ischemic mitral valve regurgitation: a randomized trial. J Thorac
Cardiovasc Surg 2009;138:278-85.
113. Pu M, Thomas JD, Gillinov MA, Griffin BP, Brunken RC. Importance
of ischemic and viable myocardium for patients with chronic
ischemic mitral regurgitation and left ventricular dysfunction. Am
J Cardiol 2003;92:862-4.
114. McGee EC Jr, Gillinov AM, Blackstone EH, Rajeswaran J, Cohen
G, Najam F, et al. Recurrent mitral regurgitation after annuloplasty
for functional ischemic mitral regurgitation. J Thorac Cardiovasc
Surg 2004;128:916-24.
115. Fattouch K, Sampognaro R, Speziale G, Salardino M, Novo G,
Caruso M, et al. Impact of moderate ischemic mitral regurgitation
after isolated coronary artery bypass grafting. Ann Thorac Surg
2010;90:1187-94.
116. Chan KM, Punjabi PP, Flather M, Wage R, Symmonds K, Roussin
I, et al; RIME Investigators. Coronary artery bypass surgery with or
without mitral valve annuloplasty in moderate functional ischemic
mitral regurgitation: final results of the Randomized Ischemic Mitral
Evaluation (RIME) trial. Circulation 2012;126:2502-10.
117. Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz
RJ, et al. Preoperative left ventricular dimensions predict reverse
remodelling following restrictive mitral annuloplasty in ischaemic
mitral regurgitation. Eur J Cardiothorac Surg 2005;27:847-53.
118. Ciarka A, Braun J, Delgado V, Versteegh M, Boersma E, Klautz
R, et al. Predictors of mitral regurgitation recurrence in patients with
heart failure undergoing mitral valve annuloplasty. Am J Cardiol
2010;106:395-401.
119. Acker MA, Jessup M, Bolling SF, Oh J, Starling RC, Mann DL,
et al. Mitral valve repair in heart failure: five-year follow-up from
the mitral valve replacement stratum of the Acorn randomized trial.
J Thorac Cardiovasc Surg 2011;142:569-74.
120. Vassileva CM, Boley T, Markwell S, Hazelrigg S. Meta-analysis
of short-term and long-term survival following repair versus replacement
for ischemic mitral regurgitation. Eur J Cardiothorac Surg
2011;39:295-303.
121. Langer F, Kunihara T, Hell K, Schramm R, Schmidt KI, Aicher
D, et al. Ring+string: successful repair technique for ischemic mitral
regurgitation with severe leaflet tethering. Circulation 2009;120(11
Suppl):S85-91.
DEFINICIÓN
ESTENOSIS AÓRTICA
La estenosis aórtica (EAo) es la obstrucción al flujo de
sangre entre el ventrículo izquierdo y la aorta generada
por el engrosamiento y la rigidez de la válvula,
secundaria a diferentes mecanismos inflamatorios o
malformativos congénitos.